With reference to CDSL’s Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, Panacea Biotec has informed that it enclosed the data of shares dematerialized during the month of August, 2023 as Annexure - 1. The company has confirmed that the total number of shares dematerialized as on August 31, 2023, were as: NSDL 5,45,07,156: CDSL 65,64,359 = Total 6,10,71,515. A copy of the certificate obtained from the Company’s RTA - Skyline Financial Services regarding shares dematerialized as on August 31, 2023 is also enclosed as Annexure -2.
The above information is a part of company’s filings submitted to BSE.
